![IJMS | Free Full-Text | The Synergistic Potential of Combining PD-1/PD-L1 Immune Checkpoint Inhibitors with NOD2 Agonists in Alzheimer’s Disease Treatment IJMS | Free Full-Text | The Synergistic Potential of Combining PD-1/PD-L1 Immune Checkpoint Inhibitors with NOD2 Agonists in Alzheimer’s Disease Treatment](https://pub.mdpi-res.com/ijms/ijms-24-10905/article_deploy/html/images/ijms-24-10905-g003a.png?1688105603)
IJMS | Free Full-Text | The Synergistic Potential of Combining PD-1/PD-L1 Immune Checkpoint Inhibitors with NOD2 Agonists in Alzheimer’s Disease Treatment
![Predicting functional effects of missense variants in voltage-gated sodium and calcium channels | Science Translational Medicine Predicting functional effects of missense variants in voltage-gated sodium and calcium channels | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aay6848/asset/85c15b55-b9e1-410f-aa3e-bdbe90dcd482/assets/graphic/aay6848-f1.jpeg)
Predicting functional effects of missense variants in voltage-gated sodium and calcium channels | Science Translational Medicine
![Cells | Free Full-Text | Olaparib-Resistant BRCA2MUT Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival Cells | Free Full-Text | Olaparib-Resistant BRCA2MUT Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival](https://www.mdpi.com/cells/cells-12-01038/article_deploy/html/images/cells-12-01038-g001.png)
Cells | Free Full-Text | Olaparib-Resistant BRCA2MUT Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival
![Frontiers | SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis Frontiers | SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis](https://www.frontiersin.org/files/Articles/1271102/fimmu-14-1271102-HTML/image_m/fimmu-14-1271102-g001.jpg)
Frontiers | SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis
![PDF) Science Forum: How failure to falsify in high-volume science contributes to the replication crisis PDF) Science Forum: How failure to falsify in high-volume science contributes to the replication crisis](https://i1.rgstatic.net/publication/362565404_Science_Forum_How_failure_to_falsify_in_high-volume_science_contributes_to_the_replication_crisis/links/63057a5eacd814437fd0fb41/largepreview.png)
PDF) Science Forum: How failure to falsify in high-volume science contributes to the replication crisis
![Children | Free Full-Text | Genetic Testing in Children with Developmental and Epileptic Encephalopathies: A Review of Advances in Epilepsy Genomics Children | Free Full-Text | Genetic Testing in Children with Developmental and Epileptic Encephalopathies: A Review of Advances in Epilepsy Genomics](https://www.mdpi.com/children/children-10-00556/article_deploy/html/images/children-10-00556-g001.png)
Children | Free Full-Text | Genetic Testing in Children with Developmental and Epileptic Encephalopathies: A Review of Advances in Epilepsy Genomics
![IJMS | Free Full-Text | Modulation of AKT Pathway-Targeting miRNAs for Cancer Cell Treatment with Natural Products IJMS | Free Full-Text | Modulation of AKT Pathway-Targeting miRNAs for Cancer Cell Treatment with Natural Products](https://www.mdpi.com/ijms/ijms-24-03688/article_deploy/html/images/ijms-24-03688-g001.png)
IJMS | Free Full-Text | Modulation of AKT Pathway-Targeting miRNAs for Cancer Cell Treatment with Natural Products
![Frontiers | Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12 Frontiers | Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12](https://www.frontiersin.org/files/MyHome%20Article%20Library/863956/863956_Thumb_400.jpg)
Frontiers | Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12
![Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies | Journal of Medicinal Chemistry Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c01975/asset/images/medium/jm2c01975_0002.gif)
Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies | Journal of Medicinal Chemistry
![Protocol refinement for a diabetes pragmatic trial using the PRECIS-2 framework | BMC Health Services Research | Full Text Protocol refinement for a diabetes pragmatic trial using the PRECIS-2 framework | BMC Health Services Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12913-021-07084-x/MediaObjects/12913_2021_7084_Fig1_HTML.png)
Protocol refinement for a diabetes pragmatic trial using the PRECIS-2 framework | BMC Health Services Research | Full Text
![Biomolecules | Free Full-Text | Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer? Biomolecules | Free Full-Text | Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?](https://pub.mdpi-res.com/biomolecules/biomolecules-11-00766/article_deploy/html/images/biomolecules-11-00766-g001.png?1621584353)
Biomolecules | Free Full-Text | Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?
![Frontiers | Modeling the Human Brain With ex vivo Slices and in vitro Organoids for Translational Neuroscience Frontiers | Modeling the Human Brain With ex vivo Slices and in vitro Organoids for Translational Neuroscience](https://www.frontiersin.org/files/Articles/838594/fnins-16-838594-HTML/image_m/fnins-16-838594-g001.jpg)
Frontiers | Modeling the Human Brain With ex vivo Slices and in vitro Organoids for Translational Neuroscience
![The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID | Signal Transduction and Targeted Therapy The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-023-01640-z/MediaObjects/41392_2023_1640_Fig1_HTML.png)
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID | Signal Transduction and Targeted Therapy
![Frontiers | Voltage-Gated Ca2+-Channel α1-Subunit de novo Missense Mutations: Gain or Loss of Function – Implications for Potential Therapies Frontiers | Voltage-Gated Ca2+-Channel α1-Subunit de novo Missense Mutations: Gain or Loss of Function – Implications for Potential Therapies](https://www.frontiersin.org/files/Articles/634760/fnsyn-13-634760-HTML/image_m/fnsyn-13-634760-g001.jpg)
Frontiers | Voltage-Gated Ca2+-Channel α1-Subunit de novo Missense Mutations: Gain or Loss of Function – Implications for Potential Therapies
![Frontiers | Successes and challenges in modeling heterogeneous BRAFV600E mutated central nervous system neoplasms Frontiers | Successes and challenges in modeling heterogeneous BRAFV600E mutated central nervous system neoplasms](https://www.frontiersin.org/files/Articles/1223199/fonc-13-1223199-HTML/image_m/fonc-13-1223199-g001.jpg)